Evidence map›Paper›PMID 42629349›Full record

ArticleScientific data2026

Glioblastoma MRI Dataset with Standardized Preprocessing, Expert-Validated Segmentation, and MGMT Profiling.

Elena Filimonova, Augusto Leone, Francesco Carbone, Matteo Zoli, Jamil Rzaev, Mariya Schukina, Alessandro Carretta, Andrea Bianconi, Fabio Cofano, Alberto Morello and 20 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Elena Filimonova *Federal Neurosurgical Center, 132/1 Nemirovicha-Danchenko St, Novosibirsk, 630087, Russia.
Augusto Leone *Department of Neurosurgery, Städtisches Klinikum Karlsruhe, Karlsruher Neurozentrum, Karlsruhe, Germany.
Francesco CarboneDepartment of Neurosurgery, Städtisches Klinikum Karlsruhe, Karlsruher Neurozentrum, Karlsruhe, Germany. francesco.carbone615@gmail.com.
Matteo ZoliDepartment of Biomedical and Neuromotor Sciences (DIBINEM), "Alma Mater Studiorum" University of Bologna, Bologna, Italy.
Jamil RzaevFederal Neurosurgical Center, 132/1 Nemirovicha-Danchenko St, Novosibirsk, 630087, Russia.
Mariya SchukinaFederal Neurosurgical Center, 132/1 Nemirovicha-Danchenko St, Novosibirsk, 630087, Russia.
Alessandro CarrettaDepartment of Biomedical and Neuromotor Sciences (DIBINEM), "Alma Mater Studiorum" University of Bologna, Bologna, Italy.
Andrea BianconiDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, 16132, Genova, Italy.
Fabio CofanoDepartment of Neurosurgery, AOU Città della Salute e della Scienza, Turin, Italy.
Alberto MorelloDepartment of Neurosurgery, AOU Città della Salute e della Scienza, Turin, Italy.
Daniele ArmocidaDepartment of Neurosurgery, AOU Città della Salute e della Scienza, Turin, Italy.
Uwe SpetzgerDepartment of Neurosurgery, Städtisches Klinikum Karlsruhe, Karlsruher Neurozentrum, Karlsruhe, Germany.
Safwan RoumiaDepartment of Radiology, Division of Neuroradiology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
Veronica Di NapoliDepartment of Neurosurgery, University of Turin, Turin, Italy.
Nicola Pio FochiDepartment of Neurosurgery, University of Turin, Turin, Italy.
Ruth LauNeurosurgery Department, Hospital Universitari Joan XXIII, Tarragona, Spain.
Valeria InternòDivision of Medical Oncology, A.O.U. Consorziale Policlinico Di Bari, Bari, Italy.
Guido GiordanoUnit of Medical Oncology and Biomolecular Therapy and CREATE Center for Research and Innovation Medicine, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy.
Antonello CurcioFondazione IRCCS Casa Sollievo della Sofferenza, UOC di Neurochirurgia, San Giovanni Rotondo, Italy.
Arianna RusticiNeuroradiology Unit, Ospedale Maggiore, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Flavio AngileriDepartment of Biomedical Sciences, Dental Sciences and Morpho-functional Imaging, University of Messina, Messina, Italy.
Diego MazzatentaDepartment of Biomedical and Neuromotor Sciences (DIBINEM), "Alma Mater Studiorum" University of Bologna, Bologna, Italy.
Francesco SignorelliDivision of Neurosurgery, Department of Translational Biomedicine and Neurosciences, University "Aldo Moro" of Bari, Bari, Italy.
Camillo PortaInterdisciplinary Department of Medicine, University of Bari "Aldo Moro" and Division of Medical Oncology, A.O.U. Consorziale Policlinico Di Bari, Bari, Italy.
Diego GarbossaDepartment of Neurosurgery, AOU Città della Salute e della Scienza, Turin, Italy.
Minh Sao Khue LuuThe Artificial Intelligence Research Center of Novosibirsk State University, 1 Pirogov St, Novosibirsk, 630090, Russia.
Margaret BenedichukThe Artificial Intelligence Research Center of Novosibirsk State University, 1 Pirogov St, Novosibirsk, 630090, Russia.
Ahsan ShakoorThe Artificial Intelligence Research Center of Novosibirsk State University, 1 Pirogov St, Novosibirsk, 630090, Russia.
Bair TuchinovThe Artificial Intelligence Research Center of Novosibirsk State University, 1 Pirogov St, Novosibirsk, 630090, Russia. bairt@nsu.ru.
Antonio ColamariaDivision of Neurosurgery, University Hospital of Foggia, Foggia, Italy.

Funding

Ministry of Economic Development of the Russian Federation 139-15-2025-006: IGK 000000C313925P3S0002
6 · The paper itself

Abstract

Glioblastoma research increasingly relies on large, well-curated imaging datasets that combine standardized MRI data, accurate tumor segmentations, and molecular profiling. We constructed a multi-center dataset of preoperative MRI scans from 337 patients with histologically confirmed primary glioblastoma collected across eight hospitals. All cases include T1-weighted (pre- and post-contrast), T2-weighted, and FLAIR sequences. Images underwent systematic quality assessment, BIDS organization, defacing, skull stripping, and linear registration to the MNI152 template. Tumor segmentation was performed using a SegResNet CNN model following the BraTS labeling convention, with all masks reviewed and manually refined by neuroradiologists. MGMT promoter methylation status was determined for all patients. This dataset provides a robust, clinically representative resource for radiomics, deep learning, and radiogenomic research in glioblastoma, supporting concrete downstream tasks including automated segmentation benchmarking (mean Dice = 0.94) and MGMT methylation prediction (baseline ACC = 0.60). Its multi-center origin, comprehensive preprocessing, expert-refined segmentations, and complete MGMT annotations address limitations of existing datasets and support the development and validation of reproducible imaging biomarkers.

Indexed as

Brain NeoplasmsDNA Modification MethylasesDNA Repair EnzymesGlioblastomaMagnetic Resonance ImagingTumor Suppressor ProteinsDNA MethylationHumansRadiomicsDNA Modification MethylasesDNA Repair EnzymesMGMT protein, humanTumor Suppressor Proteins

Identifiers

PMID42629349
PMCPMC13498554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.